ATARA BIOTHERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Increase (Decrease) in Other Noncurrent Assets of -$19.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2025-03-07
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was -$19.00K.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was -$1.04M, a 492.11% decline from fiscal 2022.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was $266.00K, a 84.60% decline from fiscal 2021.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2021 was $1.73M, a 688.58% increase from fiscal 2020.
| Period end | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|
| 2024-12-31 | -$19.00K 10-K · filed 2025-03-07 |
| 2023-12-31 | -$1.04M 10-K · filed 2025-03-07 |
| 2022-12-31 | $266.00K 10-K · filed 2024-03-28 |
| 2021-12-31 | $1.73M 10-K · filed 2023-02-08 |
| 2020-12-31 | $219.00K 10-K · filed 2023-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |